Spots Global Cancer Trial Database for Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer
Official Title:
Study ID: NCT00040638
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Cancer Center, Tucson, Arizona, United States
UCLA Medical Center, Los Angeles, California, United States
M.D. Anderson Cancer Center, Houston, Texas, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
